With the aid of CRISPR gene editing techniques, researchers have identified a new biomarker for Alzheimer's disease. The study reports a deficiency of the protein STIM1 could be implicated in the sporadic version of the neurodegenerative disease.
Researchers use CRISPR gene editing technology to target GABA receptors in order to help treat mood disorders.
Researchers have successfully reduced some symptoms associated with fragile X syndrome in mice with the help of CRISPR-Cas 9 gene editing.
A new gene editing study reveals how the hormone leptin can help to prevent diabetes and obesity.
Using CRISPR, researchers have identified a new set of genes that may be implicated in both ALS and frontotemporal dementia.
A new study reports researchers have developed a new gene editing approach that may provide a new treatment avenue for Huntington's disease.
Researchers have derived purkinje cells from patients with TSC, a genetic syndrome that includes some ASD-like symptoms. The cells, researchers say, have several characteristics that could help explain how ASD develops at the molecular level.
Max Planck researchers announce they have developed a new tool that can assist with precise genome editing in neurons.
A new study sheds light on the mechanisms of gyrus formation.
Using CRISPR gene editing technology, researchers target the Shank3 gene in monkey embryos. Research backs previous findings of the importance of the Shank3 gene for brain development and its role in autism.
CRISPR technology and advanced screening techniques allow researchers to comb through over 1500 genetic combinations to find multiple drivers of glioblastoma brain cancer.
A new study reveals the role circular RNA plays in brain function, including synaptic transmission and sensorimotor gating.
